RegWatch for Pharmaceutical Manufacturers

Stay ahead of pharmaceutical regulatory change—without adding more manual work.

Monitor the FDA, pharmaceutical quality, safety reporting, labeling, supply-chain, controlled-substance, environmental and workplace sources your organization selects. When something changes, RegWatch helps your team understand what changed, what may be affected and what to review next.

No credit card required for the free monitoring account.
Regulatory change command center
RegWatch dashboard showing monitors, regulatory updates, policy assessments and review actions
FDA CGMP21 CFR Parts 210 & 211DSCSAPostmarketing SafetyLabeling & PromotionDEAEPAOSHA
Why RegWatch

Pharmaceutical compliance spans the product lifecycle and the supply chain.

Requirements and guidance can change across quality systems, manufacturing operations, safety surveillance, labeling, distribution and facility obligations. RegWatch brings the sources you select into a consistent monitoring and review process.

High-volume FDA updates

Rules, guidance, compliance materials, safety communications, inspection resources and enforcement information can change across multiple FDA offices.

Interconnected quality systems

A single update may affect procedures for production, validation, laboratories, suppliers, deviations, complaints or change control.

Product and supply-chain dependencies

Manufacturers may need coordinated reviews across products, sites, contract partners, trading partners and distribution operations.

Cross-functional evidence

Regulatory affairs, quality, safety, legal, supply chain and EHS teams need a shared record of what changed and how it was addressed.

Monitoring Coverage

Build a watchlist around your products, sites and operating model.

Select the agencies, source categories and operational topics that matter to your organization. Expand coverage as products, facilities, partners and obligations change.

01

CGMP and pharmaceutical quality

Selected FDA regulations, guidance and quality resources related to manufacturing methods, facilities, controls, laboratories, records and quality systems.

02

FDA guidance, inspections and enforcement

Selected FDA guidance, inspection, compliance-program, warning, recall and enforcement materials relevant to your organization’s products and operations.

03

Labeling, promotion and communications

Selected FDA labeling, safety-labeling, promotional-labeling and prescription-drug advertising materials.

04

Postmarketing safety and product quality

Selected adverse-event reporting, pharmacovigilance, product-complaint, field-action and postmarketing safety sources.

05

DSCSA and supply-chain integrity

Selected Drug Supply Chain Security Act, product-tracing, suspect-product, notification and trading-partner materials.

06

Controlled substances and facility obligations

Selected DEA requirements where applicable, plus EPA, OSHA, state licensing, hazardous-material and workplace-safety sources.

Monitor availability and applicability vary by product type, source, facility, jurisdiction and organization. Your team chooses the watchlist it wants RegWatch to follow.

How RegWatch Works

Move from “something changed” to a focused review process.

Select your monitors, receive organized change intelligence and optionally connect quality documents, policies or procedures for gap assessment.

  1. 1

    Select your monitors

    Choose the FDA, DEA, EPA, OSHA, state and other sources that matter to your products, sites and responsibilities.

  2. 2

    Review focused change summaries

    See what changed, important dates, affected topics, source links and suggested review areas.

  3. 3

    Connect documents when useful

    Upload and assign SOPs, policies, quality documents or procedures to the monitors they support.

  4. 4

    Assess gaps and document action

    Review potential gaps, ownership, next steps, review activity and supporting evidence in a consistent workflow.

Illustrative workflow

A change is detected. Your team sees the context.

New Update
1
Monitor Selected source
CGMP Safety
Actively monitoring

RegWatch follows the rule, bulletin, manual, guidance or licensing source your team selects.

2
Detect Change identified
Change Alert Detected Pharmaceutical Update
New
+
Requirement updated Source captured and compared with the previous version.

The update is captured, summarized and organized so reviewers can focus on what changed.

3
Review Context delivered
RegWatch Review Ready for your team
Ready
SummaryWhat changed
Key datesWhen it matters
PoliciesWhat to review
Next stepsWho owns action
Assigned to regulatory, quality and supply-chain reviewers

Your team receives a focused review package instead of another unstructured alert.

Built for Pharmaceutical Manufacturing

One monitoring approach across products, sites and quality functions.

RegWatch can support organizations with different product portfolios, facility types, contract relationships and operational responsibilities—without forcing every site or function into the same watchlist.

Create your free monitoring account
Branded pharmaceutical manufacturersGeneric drug manufacturersActive pharmaceutical ingredient manufacturersContract manufacturers and CDMOsPackaging and repackaging operationsMulti-site quality and regulatory organizations
What Your Team Gains

A more manageable way to stay aware, assess quality impact and document follow-through.

Less manual monitoring

Reduce repeated searches across regulatory, quality, safety and facility sources.

More focused impact reviews

Give owners the source, dates, affected topics and review context in one place.

Better document alignment

Connect selected requirements with SOPs, policies and quality documents.

A clearer inspection trail

Keep updates, assessments, assignments, review activity and supporting evidence organized.

Frequently Asked Questions

Pharmaceutical regulatory monitoring, organized for practical review.

Start with regulatory monitoring, then add SOP, quality-document and policy assessment workflows when your team is ready.

Talk to Allgress
Which pharmaceutical manufacturing sources can RegWatch monitor?

Organizations can select from available FDA regulations, guidance, quality, inspection, safety, labeling, enforcement and DSCSA sources, plus selected DEA, EPA, OSHA and state materials. Available coverage depends on the selected monitors and sources.

Can we organize monitoring by product, site or function?

Yes. Your watchlist and document assignments can be organized around the products, facilities, jurisdictions and functional responsibilities your organization selects.

Can we use RegWatch without uploading SOPs or policies?

Yes. You can use RegWatch for monitoring and organized change summaries without uploading documents. Uploads are optional and enable document assessment workflows.

How does document gap assessment work?

You assign uploaded SOPs, policies or procedures to relevant monitors. When selected requirements change, RegWatch can identify areas that may require review, clarification or remediation.

Does RegWatch determine whether a requirement applies to a product or site?

No. RegWatch provides regulatory intelligence, workflow support and document assessment assistance. Your organization remains responsible for applicability decisions and for obtaining legal, regulatory, quality or other professional advice where needed.

Start with the sources that matter to you

Make pharmaceutical regulatory monitoring easier to manage.

Get a free RegWatch account and begin building your organization’s monitoring watchlist.

Start Monitoring for Free